Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of BTLA polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Mouse |
| Host species | Goat |
| Applications | ELISA,WB-Ti |
More info about BTLA polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB11450 |
| Product name: | BTLA polyclonal antibody |
| Product description: | Goat polyclonal antibody raised against synthetic peptide of BTLA. |
| Gene id: | 151888 |
| Gene name: | BTLA |
| Gene alias: | BTLA1|CD272|FLJ16065|MGC129743 |
| Gene description: | B and T lymphocyte associated |
| Immunogen: | A synthetic peptide corresponding to human BTLA. |
| Immunogen sequence/protein sequence: | KEAPTEYASICVRS |
| Protein accession: | NP_861445.3;NP_001078826.1 |
| Form: | Liquid |
| Concentration: | 0.5 mg/mL |
| Recommend dilutions: | ELISA (1:4000) Western Blot (1-3 ug/mL) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In Tris saline, pH 7.3 (0.5% BSA, 0.02% sodium azide) |
| Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Quality control testing: | Antibody Reactive Against Synthetic Peptide. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Goat |
| Antigen species / target species: | Human |
| Reactivity: | Mouse |
| Application image: |  |
| Application image note: | BTLA polyclonal antibody (Cat # PAB11450) (1 ug/mL) staining of mouse spleen lysate (35 ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence. |
| Applications: | ELISA,WB-Ti |
| Shipping condition: | Dry Ice |
| Publications: | Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responses.Lasaro MO, Tatsis N, Hensley SE, Whitbeck JC, Lin SW, Rux JJ, Wherry EJ, Cohen GH, Eisenberg RJ, Ertl HC. Nat Med. 2008 Feb;14(2):205-12. Epub 2008 Jan 13. |